Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.235 SEK | +4.44% | 0.00% | -53.37% |
04-22 | Lipidor AB Postpones the Publication of Annual Report for 2023 | CI |
03-21 | Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.37% | 603K | |
+31.37% | 588B | |
-2.79% | 364B | |
+19.94% | 326B | |
+5.24% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.80% | 167B | |
+0.50% | 161B |
- Stock Market
- Equities
- LIPI Stock
- News Lipidor AB
- Lipidor Seeks Approval for Late-stage Study of Plaque Psoriasis Medicine in India